ADENURIC

Brand name authorized in: Austria Australia Cyprus Germany Spain Finland France Ireland Italy Lithuania Netherlands New Zealand Poland United Kingdom

Active ingredients

The drug ADENURIC contains one active pharmaceutical ingredient (API):

1 Febuxostat
UNII 101V0R1N2E - FEBUXOSTAT

Uric acid is the end product of purine metabolism in humans and is generated in the cascade of hypoxanthine → xanthine → uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO.

Read about Febuxostat

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
M04AA03
Febuxostat
M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production
Discover more medicines within M04AA03

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
ADENURIC Film-coated tablet
Summary of Product Characteristics (SPC)

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 10445R
DE
Bundesinstitut für Arzneimittel und Medizinprodukte
Identifier(s): 05455113, 05455136, 05455142, 05455159, 10078397, 10078405, 10261256, 11015683, 11073835, 11073841, 11479721, 11853444, 11853450, 11893768, 13902980, 13902997, 13971857, 14227405, 14260561, 14260578, 14267103, 15373592, 15373600, 15529545, 15563134, 15563140, 17161322, 17161339, 17969225
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 08447001, 08447003
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 101845, 168329
FR
Base de données publique des médicaments
Identifier(s): 61871331, 64493890
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 170310, 170312, 299543, 374287, 376203, 381148, 381150
IE
Health Products Regulatory Authority
Identifier(s): 65600, 65601, 65602
IT
Agenzia Italiana del Farmaco
Identifier(s): 039538018, 039538032
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1032555, 1032556, 1032557, 1032558, 1063623, 1063624, 1063625, 1063626, 1063627, 1063628, 1063629, 1063630, 1079546, 1079547, 1079548, 1079549, 1079550, 1079551, 1079552, 1079553, 1079554, 1079555, 1079556, 1079557
NL
Z-Index G-Standaard, PRK
Identifier(s): 101788, 101796
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 15660, 15673
PL
Rejestru Produktów Leczniczych
Identifier(s): 100221962, 100221985